Modified SALT Score for Alopecia Areata

Kasr El Aini Hospital

Status and phase: Unknown; Phase 4

Conditions: Alopecia Areata

Treatments: Other: saline; Drug: Triamcinolone Acetonide

Study type: Interventional

Funder types: Other

Identifiers

NCT04412148

EgymSALT

Details and patient eligibility

About

Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent.

Exclusion criteria

• • pregnant, and lactating females

  • Alopecia totalis or universalis or ophiasis or cicatritial alopecia
  • Usage of systemic treatment of alopecia areata 2 months prior to the study.
  • Any scalp lesion within the treated area
  • Bleeding diathesis, severe anemia or platelet disorders
  • Medical conditions such as autoimmune diseases.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

20 participants in 2 patient groups, including a placebo group

Intralesional Steroids

Active Comparator group

Treatment:

Drug: Triamcinolone Acetonide

Control

Placebo Comparator group

Treatment:

Other: saline